Article Listing - SHA to fund Roche breast cancer drug Avastin in London

NEG LIST TALKS CONTINUE IN SPAIN

27 April 1992

Talks are continuing between the Spanish Health Ministry and the Spanish pharmaceutical industry association, Farmaindustria, on the selective financing of...

SOTALOL BEST, SAYS ARRHYTHMIA STUDY

27 April 1992

Results of an arm of the ESVEM (electrophysiologic study versus electrocardiographic monitoring) study have indicated that the beta blocker and...

IMMUNOMEDICS PRESIDENT RESIGNS

27 April 1992

Russell McLauchlan has resigned as president of Immuno-medics. According to the company, a successor is expected to be announced by...

BELMAC EUROPE LAUNCHES EPO PRODS

27 April 1992

Belmac Europe has launched three oral powder formulations of erythromycin, under the trade name Biolid, onto the French market. The...

EUROCETUS TO MARKET PROLEUKIN

27 April 1992

US pharmaceutical company Chiron's Dutch subsidiary, EuroCetus BV, has received approval from the Austrian Board of Health to market Proleukin...

"STRINGS" WITH US ACCELERATED APPRO

27 April 1992

The accelerated approval proposal which the US Food and Drug Administration published this month changes the set of principles which...

JAPAN'S 1st TYMPANIC THERMOMETER

27 April 1992

Japan's Tanabe Seiyaku Company and Omron Corp report that they have jointly developed a tympanic thermometer, the Quick Thermo MC-500,...

Japan FTC To Reduce Antitrust Exemptions

27 April 1992

Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...

GERMAN HEALTH COST DEBATE HOTS UP

27 April 1992

The debate as to how to control ever-rising German health care spending has intensified with controversial new proposals from the...

INST FARMA SERONO POSTS LOWER PROFITS

27 April 1992

Instituto Farmacologico Serono, which is listed on the Rome bourse, ended 1991 with 6.7 million lire ($5.4 million) profit, down...

Showing 94351-94360 of 95576 articles